Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Dyes and methods of marking biological material
Process for the preparation of diene polymers of statistical vinylarene-diene copolymers
Implantable defibrillator systems and methods with mitigations for saturation avoidance and accommodation
Methods and systems for delivering customized advertisements
Polypropylene bottles
Polynucleotide capture materials, and methods of using same
Treatment of diabetes with milk protein hydrolysate
  Randomly Featured Patents
Sodium ferric gluconate complexes and method of manufacture thereof
Pharmaceutical preparations containing benzimidazole 2-derivatives
Chrysanthemum named `Remco Yellow`
Semiconductor laser having low current threshold
Fuel supply unit
Lead frame and semiconductor device using same
3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
Multiple axis linearly adjustable support
Polyolefinic elastomer compositions, production process and articles obtained from said compositions
Packet protection technique